Steris (STE) Free Cash Flow Growth (3y) (2021 - 2026)
Steris (STE) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 77.20% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -0.27% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -29.89% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 19.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.32% |
| Dec 31, 2025 | 20.59% |
| Sep 30, 2025 | 112.24% |
| Jun 30, 2025 | 41.25% |
| Mar 31, 2025 | 24.39% |
| Dec 31, 2024 | 14.29% |
| Sep 30, 2024 | 16.42% |
| Jun 30, 2024 | 68.30% |
| Mar 31, 2024 | 13.04% |
| Dec 31, 2023 | 4.28% |
| Sep 30, 2023 | -18.98% |
| Jun 30, 2023 | 47.20% |
| Mar 31, 2023 | 1.42% |
| Dec 31, 2022 | 14.47% |
| Sep 30, 2022 | -40.96% |
| Jun 30, 2022 | 24.83% |
| Mar 31, 2022 | -1.25% |
| Dec 31, 2021 | 25.18% |
| Sep 30, 2021 | 1.18% |
| Jun 30, 2021 | -17.49% |